Cadrenal Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $8.74-$22.90 |
Market Cap | $24.2M |
Shares Short | 28,386 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$8.72 |
News
See moreYahoo Finance • 6 days ago
Cadrenal Therapeutics GAAP EPS of -$1.31 beats by $0.18
Yahoo Finance • 7 days ago
Cadrenal Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Yahoo Finance • 3 months ago
Cadrenal Therapeutics GAAP EPS of -$1.87
About
CEO | Mr. Quang X. Pham |
CFO | Mr. Matthew K. Szot CPA, CPA |
Address | 822 A1A North, Ponte Vedra, FL, United States, 32082 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
